Merck &Co report

In other countries outside Canada and America, it is known as d. b. a. Merck sharp and dohme (MSD). The Company headquarters is in Kenilworth, New Jersey but the origin is in Amstrad which holds the company’s nominal rights to the company elsewhere. this enables it always to develop high quality drugs and in turn realise incredibly many revenues from the sales. Merck channels its products into the market by directly to the consumers and through international producers. Some of its drugs are sold through a partnership with other agencies such as Simponi Johnson and Johnson inflammatory drugs Remicade. it has rights of selling in Turkey Russia and Europe. The company also carries a lot of advertising and drug promotion, and it spends approximately $ two billion on the same.

Januvia regulates insulin level in the body after emission of heat by the body in the process of breaking down the food. For this reason, Januvia must be used in line with a body exercise and a proper diet. By regulating the insulin level, Januvia manages to control the blood sugar, therefore, treating type 2 diabetes (Thornberry, 2007). Various categories of people who are cautioned not to use the product include people with heart or kidney problems, those who are alcoholic, those with pancreas inflammation and people with a certain type of fat in their blood known as triglycerides. Zetia: Unlike Januvia that controls insulin level in the body, Zetia controls the cholesterol by reducing its amount in the body. Isentress: It is also known as Raltegravir and falls in a class of antiretroviral medicines.

Its main role is to fight the human immunodeficiency virus mainly known as HIV. These HIV viruses are dangerous and can cause immunodeficiency syndrome commonly known as AIDS. It is good to note that Isentress is a preventive drug and Not a cure drug. It is recommended for people with kidney problems, liver disease or mental issues to disclose about their status to doctor before using the drug. DeLuca Jr-Executive Vice President, Global Services, and Chief Financial Officer Mirian M. Graddick -Weir Executive Vice President, Human Resources. Financials status According to the information by the company, the current cost of company assets stands at 26. 062 M while their liability adds to 18. 13 M. The company has a large stock price of US $ 71 billion as at today.

The company is increasingly improving. The company has recorded healthy sales of its products. The sale of its products globally for the second quarter of 2018, which is September, was US$10. 465 billion. 8 profit increase which resulted in a decrease in Gross profit margin to 66. 47% that is below the average of the company. This means the company is categorised into a durable competitive advantage. Current issues The company is currently doing well. There has been an increase in revenues subsequently from 2017 when compared with the 2018 second quarter. Work Cited Freidson, E.  Profession of medicine: A study of the sociology of applied knowledge. University of Chicago Press. Lim, S. H.  Expert opinion on biological therapy, 16(3), 397-406. Martin, D. R. , Ankel, F. , Hemphill, R. , Mubaiwa, V.